Paradigm Biopharma Conducts Share Buy-back
Company Announcements

Paradigm Biopharma Conducts Share Buy-back

Paradigm Biopharmaceuticals Ltd. (AU:PAR) has released an update.

Paradigm Biopharmaceuticals Ltd. has announced the cancellation of a total of 581,570 securities as a result of an employee share scheme buy-back on April 26, 2024. The announcement affects both ordinary fully paid and restricted securities, marking a significant change in the company’s issued capital structure.

For further insights into AU:PAR stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskParadigm Biopharma Advances Phase 3 Trials Amid Financial Prudence
TipRanks Australian Auto-Generated NewsdeskParadigm Biopharmaceuticals Advances Phase 3 Trial Plans
TipRanks Australian Auto-Generated NewsdeskParadigm Biopharmaceuticals Plans New Securities Issuance
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App